Thomas Aaberg Sr. MD
Research
Publications
-
Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials.
Ophthalmol Retina Volume: 7 Page(s): 564 - 572
07/01/2023 Authors: Xue K; Hua P; Maguire MG; Daniel E; Jaffe GJ; Grunwald JE; Ying G-S; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group -
Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes.
Invest Ophthalmol Vis Sci Volume: 64 Page(s): 35
06/01/2023 Authors: Trejo Corona S; Villanueva Boone C; Ali AM; Moore C; Brown A; Munoz J; Aaberg T; Schefler AC; ARRT Study Group -
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Jpn J Ophthalmol Volume: 67 Page(s): 264 - 279
05/01/2023 Authors: Shimura M; Kitano S; Ogata N; Mitamura Y; Oh H; Ochi H; Ohsawa S; Hirakata A; YOSEMITE and RHINE Investigators -
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Ophthalmol Retina Volume: 6 Page(s): 771 - 785
09/01/2022 Authors: Core JQ; Pistilli M; Hua P; Daniel E; Grunwald JE; Toth CA; Jaffe GJ; Martin DF; Maguire MG; Ying G-S -
Intraocular Lens and Lens Capsule Spread of Iridociliary Melanoma: Clinical and Histopathologic Features of 2 Cases.
Ocul Oncol Pathol Volume: 8 Page(s): 105 - 109
06/01/2022 Authors: Azarcon CP; Wells JR; Aaberg T; Grossniklaus HE -
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Lancet Volume: 399 Page(s): 741 - 755
02/19/2022 Authors: Wykoff CC; Abreu F; Adamis AP; Basu K; Eichenbaum DA; Haskova Z; Lin H; Loewenstein A; Mohan S; Pearce IA -
Prepapillary vascular loop-a new classification.
Eye (Lond) Volume: 35 Page(s): 425 - 432
02/01/2021 Authors: Mansour AM; Kozak I; Saatci AO; Ascaso FJ; Broc L; Battaglia M; Olivier N; Gili P; Chhablani J; Hedges TR -
Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.
Graefes Arch Clin Exp Ophthalmol Volume: 258 Page(s): 427 - 435
02/01/2020 Authors: Seider MI; Berry DE; Schefler AC; Materin M; Stinnett S; Mruthyunjaya P; Ocular Oncology Study Consortium -
Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
Ophthalmology Volume: 125 Page(s): 1054 - 1063
07/01/2018 Authors: Jampol LM; Glassman AR; Liu D; Aiello LP; Bressler NM; Duh EJ; Quaggin S; Wells JA; Wykoff CC; Diabetic Retinopathy Clinical Research Network -
Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma.
Melanoma Res Volume: 28 Page(s): 120 - 125
04/01/2018 Authors: Danish H; Ferris MJ; Balagamwala E; Switchenko JM; Patel KR; Choudhary M; Craven C; Mendoza P; Suh J; Bergstrom C